These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 17429062)

  • 1. Primary aldosteronism in diabetic subjects with resistant hypertension.
    Umpierrez GE; Cantey P; Smiley D; Palacio A; Temponi D; Luster K; Chapman A
    Diabetes Care; 2007 Jul; 30(7):1699-703. PubMed ID: 17429062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
    Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary aldosteronism in diabetic subjects with resistant hypertension: response to Umpierrez et al.
    Ng YW; Tiu SC; Ng JC; Chan HY
    Diabetes Care; 2008 Jan; 31(1):e2; author reply e3. PubMed ID: 18165346
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism.
    Bernini G; Moretti A; Orlandini C; Berti P; Miccoli P; Bardini M; Taurino C; Bernini M; Salvetti A
    J Hypertens; 2008 May; 26(5):981-8. PubMed ID: 18398341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects.
    Ito Y; Takeda R; Karashima S; Yamamoto Y; Yoneda T; Takeda Y
    Hypertens Res; 2011 Jan; 34(1):98-102. PubMed ID: 20927116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening tests and diagnostic examinations of hypertensives for primary aldosteronism].
    Omura M; Nishikawa T
    Rinsho Byori; 2006 Nov; 54(11):1157-63. PubMed ID: 17240838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
    Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
    Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting and treating primary aldosteronism: primary aldosteronism.
    Mantero F; Mattarello MJ; Albiger NM
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):171-4. PubMed ID: 17427105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test.
    Fogari R; Preti P; Zoppi A; Rinaldi A; Fogari E; Mugellini A
    Hypertens Res; 2007 Feb; 30(2):111-7. PubMed ID: 17460380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone excess and resistance to 24-h blood pressure control.
    Pimenta E; Gaddam KK; Pratt-Ubunama MN; Nishizaka MK; Cofield SS; Oparil S; Calhoun DA
    J Hypertens; 2007 Oct; 25(10):2131-7. PubMed ID: 17885558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
    Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
    Rossi GP; Bernini G; Caliumi C; Desideri G; Fabris B; Ferri C; Ganzaroli C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Mattarello MJ; Moretti A; Palumbo G; Parenti G; Porteri E; Semplicini A; Rizzoni D; Rossi E; Boscaro M; Pessina AC; Mantero F;
    J Am Coll Cardiol; 2006 Dec; 48(11):2293-300. PubMed ID: 17161262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albuminuria in untreated patients with primary aldosteronism or essential hypertension.
    Halimi JM; Mimran A
    J Hypertens; 1995 Dec; 13(12 Pt 2):1801-2. PubMed ID: 8903655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension.
    Hu Y; Zhang J; Liu W; Su X
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32163576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of reference values for endocrine tests. III: Primary aldosteronism.
    Baas SJ; Endert E; Fliers E; Prummel MF; Wiersinga WM
    Neth J Med; 2003 Feb; 61(2):37-43. PubMed ID: 12735419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ovarian cycle as a factor of variability in the laboratory screening for primary aldosteronism in women.
    Fommei E; Ghione S; Ripoli A; Maffei S; Di Cecco P; Iervasi A; Turchi S
    J Hum Hypertens; 2009 Feb; 23(2):130-5. PubMed ID: 18769443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone and refractory hypertension: a prospective cohort study.
    Sartori M; Calò LA; Mascagna V; Realdi A; Macchini L; Ciccariello L; De Toni R; Cattelan F; Pessina AC; Semplicini A
    Am J Hypertens; 2006 Apr; 19(4):373-9; discussion 380. PubMed ID: 16580572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.